Chronic recurrent dehydration associated with periodic water intake exacerbates hypertension and promotes renal damage in male spontaneously hypertensive rats

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Hilliard, Lucinda M ^a   Colafella, Katrina M Mirabito ^a   Bulmer, Louise L ^a   Puelles, Victor G ^a   Singh, Reetu R ^a   Ow, Connie P C ^a   Gaspari, Tracey ^a   Drummond, Grant R ^a   Evans, Roger G ^a   Vinh, Antony ^a   Denton, Kate M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988640310     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep33855     Document Type: Article

References (42)

1. Clark, W. F. et al. Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol 6, 2634-2641, doi: 10. 2215/CJN. 01990211 (2011).
2. Sontrop, J. M. et al. Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data. Am J Nephrol 37, 434-442, doi: 10. 1159/000350377 (2013).
3. Strippoli, G. F. et al. Fluid and nutrient intake and risk of chronic kidney disease. Nephrology (Carlton) 16, 326-334, doi: 10. 1111/j. 1440-1797. 2010. 01415. x (2011).
4. Wang, C. J., Grantham, J. J. & Wetmore, J. B. The medicinal use of water in renal disease. Kidney Int 84, 45-53, doi: 10. 1038/ ki. 2013. 23 (2013).
5. Borghi, L. et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155, 839-843 (1996).
6. Embon, O. M., Rose, G. A. & Rosenbaum, T. Chronic dehydration stone disease. Br J Urol 66, 357-362 (1990).
7. Wesseling, C. et al. Resolving the enigma of the mesoAmerican nephropathy: a research workshop summary. Am J Kidney Dis 63, 396-404, doi: 10. 1053/j. ajkd. 2013. 08. 014 (2014).
8. Garcia-Trabanino, R. et al. Heat stress, dehydration, and kidney function in sugarcane cutters in El Salvador-A cross-shift study of workers at risk of MesoAmerican nephropathy. Environ Res 142, 746-755, doi: 10. 1016/j. envres. 2015. 07. 007 (2015).
9. Bankir, L., Bardoux, P., Mayaudon, H., Dupuy, O. & Bauduceau, B. Impaired urinary flow rate during the day: a new factor possibly involved in hypertension and in the lack of nocturnal dipping. Arch Mal Coeur Vaiss 95, 751-754 (2002).
10. Bouby, N., Bachmann, S., Bichet, D. & Bankir, L. Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat. Am J Physiol 258, F973-F979 (1990).
11. de Zeeuw, D. Renal disease: a common and a silent killer. Nat Clin Pract Cardiovasc Med 5 Suppl 1, S27-S35, doi: 10. 1038/ ncpcardio0853 (2008).
12. Bakoush, O. et al. Increased glomerular albumin permeability in old spontaneously hypertensive rats. Nephrol Dial Transplant 19, 1724-1731, doi: 10. 1093/ndt/gfh276 (2004).
13. Feld, L. G., Van Liew, J. B., Galaske, R. G. & Boylan, J. W. Selectivity of renal injury and proteinuria in the spontaneously hypertensive rat. Kidney Int 12, 332-343 (1977).
14. Rodriguez-Iturbe, B., Quiroz, Y., Ferrebuz, A., Parra, G. & Vaziri, N. D. Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats. Am J Nephrol 24, 587-594, doi: 10. 1159/000082313 (2004).
15. Wei, Z. et al. Differential phenotypes of tissue-infiltrating T cells during angiotensin II-induced hypertension in mice. PLoS One 9, e114895, doi: 10. 1371/journal. pone. 0114895 (2014).
16. Mirabito, K. M. et al. Role of inflammation and the angiotensin type 2 receptor in the regulation of arterial pressure during pregnancy in mice. Hypertension 64, 626-631, doi: 10. 1161/HYPERTENSIONAHA. 114. 03189 (2014).
17. Saleh, M. A. et al. Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J Clin Invest 125, 1189-1202, doi: 10. 1172/JCI76327 (2015).
18. Abrahams, J. M., Boura, A. L., Evans, R. G., Johnston, C. I. & Olley, J. E. The effects of N-(cyclopropylmethyl)-19-isopentylnororvinol (M320), a potent agonist at kappa-and mu-opiate receptors, on urine excretion of rats. Br J Pharmacol 89, 759-767 (1986).
19. Robertson, G. L., Mahr, E. A., Athar, S. & Sinha, T. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 52, 2340-2352, doi: 10. 1172/JCI107423 (1973).
20. Perrier, E. et al. Circadian variation and responsiveness of hydration biomarkers to changes in daily water intake. Eur J Appl Physiol 113, 2143-2151, doi: 10. 1007/s00421-013-2649-0 (2013).
21. Choukroun, G., Schmitt, F., Martinez, F., Drueke, T. B. & Bankir, L. Low urine flow reduces the capacity to excrete a sodium load in humans. Am J Physiol 273, R1726-R1733 (1997).
22. Sampson, A. K., Widdop, R. E. & Denton, K. M. Sex-differences in circadian blood pressure variations in response to chronic angiotensin II infusion in rats. Clin Exp Pharmacol Physiol 35, 391-395, doi: 10. 1111/j. 1440-1681. 2008. 04884. x (2008).
23. Evans, L. C. et al. Null mutation of the nicotinamide adenine dinucleotide phosphate-oxidase subunit p67phox protects the Dahl-S rat from salt-induced reductions in medullary blood flow and glomerular filtration rate. Hypertension 65, 561-568, doi: 10. 1161/ HYPERTENSIONAHA. 114. 04468 (2015).
24. Roncal Jimenez, C. A. et al. Fructokinase activity mediates dehydration-induced renal injury. Kidney Int 86, 294-302, doi: 10. 1038/ ki. 2013. 492 (2014).
25. Imig, J. D. & Ryan, M. J. Immune and inflammatory role in renal disease. Compr Physiol 3, 957-976, doi: 10. 1002/cphy. c120028 (2013).
26. Watts, A. G. NEuropeptides and the integration of motor responses to dehydration. Annu Rev Neurosci 24, 357-384, doi: 10. 1146/ annurev. neuro. 24. 1. 357 (2001).
27. Roncal-Jimenez, C., Lanaspa, M. A., Jensen, T., Sanchez-Lozada, L. G. & Johnson, R. J. Mechanisms by Which Dehydration May Lead to Chronic Kidney Disease. Ann Nutr Metab 66 Suppl 3, 10-13, doi: 10. 1159/000381239 (2015).
28. Prasad Sah, O. S. & Qing, Y. X. Associations Between Hyperuricemia and Chronic Kidney Disease: A Review. Nephrourol Mon 7, e27233, doi: 10. 5812/numonthly. 7(3)2015. 27233 (2015).
29. Johnson, R. J. et al. Uric acid and chronic kidney disease: which is chasing whicH Nephrol Dial Transplant 28, 2221-2228, doi: 10. 1093/ndt/gft029 (2013).
30. Feig, D. I. Serum uric acid and the risk of hypertension and chronic kidney disease. Curr Opin Rheumatol 26, 176-185, doi: 10. 1097/ BOR. 0000000000000033 (2014).
31. Okada, H., Suzuki, H., Kanno, Y., Yamamura, Y. & Saruta, T. Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats. Clin Sci (Lond) 86, 399-404 (1994).
32. Perico, N. et al. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction. Kidney Int 76, 960-967, doi: 10. 1038/ki. 2009. 267 (2009).
33. Sugiura, T. et al. High water intake ameliorates tubulointerstitial injury in rats with subtotal nephrectomy: possible role of TGF-beta. Kidney Int 55, 1800-1810, doi: 10. 1046/j. 1523-1755. 1999. 00443. x (1999).
34. Bouby, N., Hassler, C. & Bankir, L. Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats. Life Sci 65, 991-1004 (1999).
35. Meijer, E. et al. Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6, 361-368, doi: 10. 2215/CJN. 04560510 (2011).
36. Meijer, E. et al. Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients. Transplantation 88, 561-567, doi: 10. 1097/TP. 0b013e3181b11ae4 (2009).
37. Long, D. A., Price, K. L., Herrera-Acosta, J. & Johnson, R. J. How does angiotensin II cause renal injury? Hypertension 43, 722-723, doi: 10. 1161/01. HYP. 0000120964. 22281. 3e (2004).
38. Bankir, L., Bouby, N. & Ritz, E. Vasopressin: a novel target for the prevention and retardation of kidney disease? Nat Rev Nephrol 9, 223-239, doi: 10. 1038/nrneph. 2013. 22 (2013).
39. Schock-Kusch, D. et al. Transcutaneous assessment of renal function in conscious rats with a device for measuring FITC-sinistrin disappearance curves. Kidney Int 79, 1254-1258, doi: 10. 1038/ki. 2011. 31 (2011).
40. Vinh, A. et al. Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation 122, 2529-2537, doi: 10. 1161/CIRCULATIONAHA. 109. 930446 (2010).
41. Puelles, V. G. et al. Podocyte Number in Children and Adults: Associations with Glomerular Size and Numbers of Other Glomerular Resident Cells. J Am Soc Nephrol 26, 2277-2288, doi: 10. 1681/ASN. 2014070641 (2015).
42. Steffes, M. W., Schmidt, D., McCrery, R. & Basgen, J. M. International Diabetic Nephropathy Study, G. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 59, 2104-2113, doi: 10. 1046/j. 1523-1755. 2001. 00725. x (2001).